MARS Bioimaging Secures First Clinical Sale Of Portable Photon-Counting CT ScannerChristchurch-based Reform Radiology becomes inaugural clinical customer as New Zealand-developed photon-counting CT technology enters routine clinical practiceAdvanced photon-counting CT technology delivers high-resolution 3D colour-enabled X-ray imaging at the point of careMARS Bioimaging, a New Zealand–headquartered medical device company, has secured the first clinical sale of its portable photon-counting CT scanner for upper extremity imaging, with Christchurch-based Reform Radiology becoming the inaugural clinical customer to introduce the technology as part of its specialist musculoskeletal imaging service. Dr Ojas Mahapatra, Group Chief Executive Officer of MARS Bioimaging, says the sale marks a defining milestone in the company's commercial journey. MARS Bioimaging Extremity Imaging System, a portable photon-counting CT system for upper extremity imaging (Photo/Supplied)With the installation, patients referred to Reform Radiology will be among the first in the world to access the MARS Extremity Imaging System as part of routine clinical care. We're excited to become the first clinical customer and reference site for the MARS Extremity Imaging System. The MARS Extremity Imaging SystemThe MARS Extremity Imaging System is the world's first portable photon-counting CT scanner for upper extremity imaging.